INC Research CEO elected as 2015 ACRO Chairman

By Zachary Brennan contact

- Last updated on GMT

INC Research CEO elected ACRO chairman
INC Research CEO elected ACRO chairman

Related tags: Management occupations

The Board of Directors of the Association of Clinical Research Organizations (ACRO) has elected Jamie Macdonald, CEO of INC Research, as its 2015 chairman and David Simmons, Chairman and CEO of PPD, as vice chairman.

I am pleased to lead ACRO at a time when our industry is exerting its voice on important policy matters in the US, Europe and globally while also strengthening our relationships with research sponsors and sites​,” Macdonald said. “Wesee further opportunities in the year ahead to build deeper connections into the research site and patient communities​.”

Macdonald will replace Icon CEO Ciaran Murray as the ACRO chairman. Murray told us last year​ that he expects more steady growth from the outsourcing industry in the near-term, especially when compared to the more drastic growth in the years prior.

Macdonald also highlighted some of ACRO’s 2014 accomplishments, including: advocating to expand the US Research & Development tax credit to CROs​, which died in the Senate Finance Committee​ before reaching a vote, as well as the 21st Century Cures initiative, which aims to amend the federal drug and device approval apparatus to keep it up to speed with research developments.

John Lewis, SVP of ACRO, told Outsourcing-Pharma.com that ACRO is meeting with staff from the House Energy and Commerce committee to discuss some of the Cures legislation, though he did not elaborate further.

ACRO also has been busy representing CRO interests in the implementation of the European Clinical Trials Regulation; the formation of the CRO Forum to interact with TransCelerate Biopharma​; and conducting research on the growth and expertise of the CRO industry.

ACRO members represent more than two-thirds of contract biopharmaceutical research activity globally and we expect to further increase our membership this year as more CROs see the value of active participation in the association​,” said ACRO Executive Director Doug Peddicord.

ACRO also elected Judd Hartman, General Counsel of PPD, as Secretary; and Christopher Gaenzle, Chief Administrative Officer and General Counsel of INC Research, as Treasurer. 

Related news

Show more

Related products

show more

Using SDTM, ADaM, and SEND

Using SDTM, ADaM, and SEND

Formedix | 09-Nov-2022 | Technical / White Paper

This article gives an overview of SDTM, ADaM, SEND and ARM, and discusses how these CDISC standards fit in with the wider clinical trial process, and how...

How to design an effective CRF

How to design an effective CRF

Formedix | 10-Oct-2022 | Technical / White Paper

CRFs and eCRFs are used for gathering patient data during clinical trials. They play a crucial role in helping to assess the safety and efficacy of clinical...

The Complexities of Ophthalmic Drug Development

The Complexities of Ophthalmic Drug Development

Altasciences | 04-Oct-2022 | Technical / White Paper

Ophthalmic drug development comes with a unique set of challenges that can be mitigated by working with an end-to-end solution provider with regulatory...

Because When It's On the Line... Capability Matters.

Because When It's On the Line... Capability Matters.

Baxter BioPharma Solutions | 01-Oct-2022 | Product Brochure

Baxter’s BioPharma Solutions business supports leading pharmaceutical companies in meeting their commercialization objectives by providing scientific expertise,...

Related suppliers

Follow us

Products

View more

Webinars